Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial

已完结 20 由 xy 发布于 2026/6/26 11:50:24

DOI:10.1016/S2352-3026(25)00144-9
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/s2352-3026(25)00144-9

其它数据库

Abstract：Two doses of subcutaneous blinatumomab in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia were identified as preliminary recommended phase 2 doses, based on the dos

应助信息

4小时前

lren

280ff51d711311f183e834735aa3bc31.pdf 已采纳

4小时前

Book学术机器人

2026/6/26 11:50:24 未找到该文献，机器人已退出，请等待人工下载

2026/6/26 11:50:24 Book学术AI机器人收到请求，开始寻找文献

2026/6/26 11:50:24 已向机器人发送请求

4小时前

xy 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Influence of microplastics on soil aggregate formation: Insights into biological binding agents